Key result
Baseline serum lactate predicted 30-day mortality, and a 50% reduction in lactate within 6 hours was associated with improved survival.
Why the study?
Cardiogenic shock complicating acute myocardial infarction carries high mortality, prompting investigation into serial lactate measurements and relative lactate changes for prognosis after intensive care initiation.
Do baseline serum lactate and its relative change predict 30-day mortality in patients with cardiogenic shock?
Observational (n=219)
Do baseline serum lactate and its relative change predict 30-day mortality in patients with cardiogenic shock?
Baseline serum lactate and its relative reduction within the first 24 hours are significant predictors of 30-day mortality in patients with cardiogenic shock.
Answers are grounded in this paper and cite their sources.
Serial lactate trends refine mortality risk in MI cardiogenic shock; extends CardShock data to support routine monitoring in intensive care.
INTRODUCTION: Cardiogenic shock complicating acute myocardial infarction has a very high mortality. Our present study focuses on serial measurement of lactate during admission due to cardiogenic shock and the prognostic effect of lactate and a relative change in lactate in patients after admission and the institution of intensive care treatment. METHODS AND RESULTS: This is a secondary analysis of the CardShock study. Data on lactate at baseline were available on 217 of 219 patients.In the study population, the median baseline lactate was 2.8 mmol/L (min-max range, 0.5-23.1 mmol/L).At admission, lactate was predictive of 30-day mortality with an adjusted Hazard ratio (HR) of 1.20 mmol/L (95% confidence interval, CI 1.14-1.27). Within the first 24 h of admission, baseline lactate remained predictive of 30-day mortality. Lactate at 6 h had a HR of 1.14 (95% CI 1.06-1.24) and corresponding values at 12 and 24 h had a HR of 1.10 (1.04-1.17), and of HR 1.19 (95% CI 1.07-1.32), respectively. A 50% reduction in lactate within 6 h resulted in a HR of 0.82 (95% CI 0.72-0.94). Corresponding hazard ratios at 12 and 24 h, were 0.87 (95% CI 0.76-0.98) and 0.74 (95% CI 0.60-0.91), respectively. CONCLUSION: The main findings of the present study are that baseline lactate is a powerful predictor of 30-day mortality, lactate at 6, 12, and 24 h after admission are predictors of 30-day mortality, and a relative change in lactate is a significant predictor of survival within the first 24 h after instituting intensive care treatment adding information beyond the information from baseline values.
No takes yet. Share an insight, caveat, or question.
Lindholm et al. (2019) conducted an observational in Cardiogenic shock complicating acute myocardial infarction (n=219). Serum lactate and relative change in lactate was evaluated on 30-day mortality (HR 1.20, 95% CI 1.14-1.27). Baseline serum lactate predicted 30-day mortality, and a 50% reduction in lactate within 6 hours was associated with improved survival.
Synapse has enriched 10 related papers. Consider them for comparative context: